Chapter 90 - Hirsutism and Hypertrichosis Flashcards
TABLE 90-1
Causes of Hirsutism
FINDINGS
- Regular ovulation and normal to slightly elevated androgen levels
- Often presents with mild to moderate hirsutism
Idiopathic hirsutism (IH)
TABLE 90-1
Causes of Hirsutism
FINDINGS
Hyperandrogenism; menstrual irregularities, including oligomenorrhea, amenorrhea, and infertility; and impaired glucose tolerance, hyperlipidemia, and obesity
Polycystic ovarian syndrome (PCOS)
TABLE 90-1
Causes of Hirsutism
FINDINGS
- Autosomal recessive inheritance of 21-hydroxylase deficiency
- Rarely secondary to 11β-hydroxylase deficiency
- Hirsutism, acne, alopecia, anovulation, and menstrual dysfunction
Nonclassic congenital adrenal hyperplasia
TABLE 90-1
Causes of Hirsutism
FINDINGS
- Hyperandrogenism, insulin resistance, and acanthosis nigricans
- Considered a subtype of PCOS
HAIR-AN
Hyperandrogenism (HA), insulin resistance (IR), and acanthosis nigricans (AN)
TABLE 90-1
Causes of Hirsutism
FINDINGS
Seborrhea, acne, hirsutism, and alopecia
SAHA
TABLE 90-1
Causes of Hirsutism
FINDINGS
Presents with amenorrhoea, galactorrhea, and infertility
Hyperprolactinemia
TABLE 90-1
Causes of Hirsutism
FINDINGS
Centripetal fat distribution, thinning of the skin with striae, glucose intolerance, osteoporosis, and proximal muscle weakness; signs and symptoms of hyperandrogenism and menstrual irregularities
Cushing syndrome
TABLE 90-1
Causes of Hirsutism
FINDINGS
Most common areas involved are the upper abdomen, lower abdomen, lower back, upper lip, and thighs
Pregnancy
TABLE 90-1
Causes of Hirsutism
FINDINGS
Elevated random serum GH and IGF-1
Acromegaly
TABLE 90-1
Causes of Hirsutism
COMMENT
Mean age, BMI, and hip and waist circumference higher in these patients vs patients with metabolic disturbance
Idiopathic hirsutism (IH)
TABLE 90-1
Causes of Hirsutism
COMMENT
- Cutaneous findings of acanthosis nigricans may also be observed in 5% of obese women with insulin resistance
- Warrants endocrinology evaluation for impaired glucose tolerance as increased risk for type 2 diabetes mellitus
Polycystic ovarian syndrome (PCOS)
TABLE 90-1
Causes of Hirsutism
COMMENT
Patients often present accelerated bone age maturation and increased basal or stimulated 17-OHP
Nonclassic congenital adrenal hyperplasia
TABLE 90-1
Causes of Hirsutism
COMMENT
Insulin elevated; elevated or high-normal levels of testosterone and androstenedione but normal levels of LH and prolactin
HAIR-AN
Hyperandrogenism (HA), insulin resistance (IR), and acanthosis nigricans (AN)
TABLE 90-1
Causes of Hirsutism
COMMENT
Associated with stress, pituitary adenoma, pregnancy, drug intake, and primary hypothyroidism with elevated TSH
Hyperprolactinemia
TABLE 90-1
Causes of Hirsutism
COMMENT
Multiple causes:
- Adrenal neoplasm
- Ectopic ACTH-secreting tumor
- Pituitary tumor (Cushing disease)
Cushing syndrome
TABLE 90-1
Causes of Hirsutism
COMMENT
- Serum total testosterone levels and mFG score increase with the progression of this condition
- Associated with physiological changes of this condition
Pregnancy
TABLE 90-1
Causes of Hirsutism
COMMENT
Patients can present with abnormal growth of the hands and feet, arthritis, sleep apnea, headache, and impaired vision
Acromegaly
TABLE 90-2
Pharmacologic Treatment of Hirsutism
MECHANISM OF ACTION
- Suppress ovarian androgen synthesis
- Increase SHBG
Oral contraceptive pills (OCPs)
TABLE 90-2
Pharmacologic Treatment of Hirsutism
MECHANISM OF ACTION
- Competitive inhibitor of AR and 5α-reductase
- Increases SHBG
- Decreases androgen synthesis
Spironolactone
TABLE 90-2
Pharmacologic Treatment of Hirsutism
MECHANISM OF ACTION
Competes with DHT for binding to the androgen receptor
Cyproterone acetate
TABLE 90-2
Pharmacologic Treatment of Hirsutism
MECHANISM OF ACTION
Nonsteroidal competitive inhibitor of androgen receptor binding
Flutamide and bicalutamide
TABLE 90-2
Pharmacologic Treatment of Hirsutism
MECHANISM OF ACTION
Suppress adrenal function
Glucocorticoids
TABLE 90-2
Pharmacologic Treatment of Hirsutism
MECHANISM OF ACTION
Suppresses gonadotropin and ovarian androgen secretion
GnRH agonist
(Leuprolide acetate, depot suspension)
TABLE 90-2
Pharmacologic Treatment of Hirsutism
MECHANISM OF ACTION
Cytochrome P450 enzyme inhibitor and decreases adrenal steroid production
Ketoconazole
TABLE 90-2
Pharmacologic Treatment of Hirsutism
MECHANISM OF ACTION
Inhibits 5α-reductase
Finasteride
TABLE 90-2
Pharmacologic Treatment of Hirsutism
MECHANISM OF ACTION
Insulin-sensitizing agent
Metformin
TABLE 90-2
Pharmacologic Treatment of Hirsutism
DOSAGE
Oral contraceptive pills (OCPs)
Single pill a day
TABLE 90-2
Pharmacologic Treatment of Hirsutism
DOSAGE
Spironolactone
Starting dosage is 50 mg twice daily and may be increased to a total daily dose of 200 mg
TABLE 90-2
Pharmacologic Treatment of Hirsutism
DOSAGE
Cyproterone acetate
Low dose (2 mg) in OCPs 12.5-100 mg as monotherapy or with estrogen
TABLE 90-2
Pharmacologic Treatment of Hirsutism
DOSAGE
Flutamide
62.5–250 mg, twice daily
TABLE 90-2
Pharmacologic Treatment of Hirsutism
DOSAGE
Bicalutamide
25 mg/day
TABLE 90-2
Pharmacologic Treatment of Hirsutism
DOSAGE
Prednisone
5-7.5 mg by mouth at bedtime
TABLE 90-2
Pharmacologic Treatment of Hirsutism
DOSAGE
Dexamethasone
0.5 mg at bedtime
TABLE 90-2
Pharmacologic Treatment of Hirsutism
DOSAGE
GnRH agonist (Leuprolide acetate, depot suspension)
7.5 mg monthly intramuscularly, with 25–50 ug of transdermal estradiol
TABLE 90-2
Pharmacologic Treatment of Hirsutism
DOSAGE
Ketoconazole
400–600 mg by mouth daily
TABLE 90-2
Pharmacologic Treatment of Hirsutism
DOSAGE
Finasteride
1–5 mg by mouth
TABLE 90-2
Pharmacologic Treatment of Hirsutism
DOSAGE
Metformin
850 mg twice a day or 500 mg three times a day
TABLE 90-2
Pharmacologic Treatment of Hirsutism
ADVERSE EFFECTS
- Headaches
- Migraines
- Risk of venous thromboembolic event
- Melasma
- Alopecia (upon discontinuation)
Oral contraceptive pills (OCPs)
TABLE 90-2
Pharmacologic Treatment of Hirsutism
ADVERSE EFFECTS
- Polyuria
- Hypotension
- Headaches
- Fatigue
- Syncope
- Hyperkalemia
- Irregular menses
- Teratogen
- Decreased libido
Spironolactone
TABLE 90-2
Pharmacologic Treatment of Hirsutism
ADVERSE EFFECTS
- Fluid retention
- Depression
- Menstrual irregularities
- Teratogen
- Increased risk of liver dysfunction
Cyproterone acetate
TABLE 90-2
Pharmacologic Treatment of Hirsutism
ADVERSE EFFECTS
- Teratogen
- Hepatotoxicity
- Diarrhea
- Nausea
- Vomiting
Flutamide and bicalutamide
TABLE 90-2
Pharmacologic Treatment of Hirsutism
ADVERSE EFFECTS
- Hyperglycemia
- Hypertension
- Cushingoid changes
- Esophageal reflux and peptic ulcer disease
- Psychosis and agitation
- Increased risk of infections
- Adrenal suppression
Glucocorticoids
TABLE 90-2
Pharmacologic Treatment of Hirsutism
ADVERSE EFFECTS
Osteoporosis if not combined with estrogen–progestin
GnRH agonist
(Leuprolide acetate, depot suspension)
TABLE 90-2
Pharmacologic Treatment of Hirsutism
ADVERSE EFFECTS
- Headache
- Nausea
- Hair loss
Ketoconazole
TABLE 90-2
Pharmacologic Treatment of Hirsutism
ADVERSE EFFECTS
- Headaches
- Decreased libido
Finasteride
TABLE 90-2
Pharmacologic Treatment of Hirsutism
ADVERSE EFFECTS
- Rare lactic acidosis
- GI distress
Metformin
TABLE 90-2
Pharmacologic Treatment of Hirsutism
COMMENTS
- First-line therapy (in women not seeking to conceive)
- Contradictions:
– Uncontrolled HTN
– Thromboembolic disorder
– Breast cancer
– Active smoker (absolutely if older than 35 yr)
– Cardiovascular disease
Oral contraceptive pills (OCPs)
TABLE 90-2
Pharmacologic Treatment of Hirsutism
COMMENTS
- Avoid combination with other potassium-sparing diuretics and thiazides
- Contraindicated in patients with renal failure
- Recommend combination with OCPs
- Pregnancy Category C
Spironolactone
TABLE 90-2
Pharmacologic Treatment of Hirsutism
COMMENTS
- Not available in the United States
- Contraindicated during pregnancy and breastfeeding and with liver diseases
Cyproterone acetate
TABLE 90-2
Pharmacologic Treatment of Hirsutism
COMMENTS
- Recommend combination with OCPs
- Pregnancy Category D
Flutamide and bicalutamide
TABLE 90-2
Pharmacologic Treatment of Hirsutism
COMMENTS
- Indicated for hirsutism secondary to CAH
- Not recommended in patients with uncontrolled diabetes and hypertension
- When used as monotherapy, does not significantly improve hirsutism
- Pregnancy Category C
Glucocorticoids
TABLE 90-2
Pharmacologic Treatment of Hirsutism
COMMENTS (2)
Pregnancy Category X
- GnRH agonist
(Leuprolide acetate, depot suspension) - Finasteride
TABLE 90-2
Pharmacologic Treatment of Hirsutism
COMMENTS
Pregnancy Category C
Ketoconazole
TABLE 90-2
Pharmacologic Treatment of Hirsutism
COMMENTS
- Must ensure normal renal function before starting
- Pregnancy Category B
Metformin